-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Down to the lowest price in the country recently, Qinghai Province pharmaceutical and medical supplies centralized procurement network issued "The Qinghai Provincial Public Medical Institutions Procurement Alliance orthopaedic joints high-value medical supplies procurement documents" (hereinafter referred to as "procurement documents"), will be orthopaedic joints category supplies final price negotiations.
specifically related to artificial knee joint, single knee system, artificial hip joint, fractured steel plate around the prosthesis, disposable bone cement vacuum mixing kit, such as 29 categories of 54 varieties of orthopaedic supplies.
"Procurement Documents" show that the declared enterprises must provide the 2019 to date Qinghai Province medical institutions sales invoices the lowest price, while providing the country's current medical institutions minimum supply price, the declared enterprise's quotation shall not be higher than the national current medical institutions minimum supply price, higher than the national current medical structure minimum supply price is considered invalid quotation.
For the specific negotiation rules, according to the number of varieties declared by enterprises, fully consider the actual clinical needs, according to the scoring criteria for comprehensive scoring, according to the comprehensive score ranking, domestic and import the first 6 declared enterprises into the negotiation bargaining process (less than 6 of the total entry).
for specific scoring criteria, including annual productivity, product certification, prosthesis survival rate, production process and other characteristics, scores of 10 to 15 points.
will then be the negotiating team in accordance with the quotation of the declared enterprises and reference enterprises to provide the 2019-to-date Qinghai Province medical institutions sales invoice first vote minimum price, the country's current medical institutions minimum supply price, and enter the negotiation and bargaining process of the declared enterprises to negotiate product prices.
agreed price divided by the enterprise quotation to form a decline, and finally according to the average decline of enterprises declared products to sort, from high to low to determine the finalists (brands), domestic enterprises shortlisted 3, import enterprises shortlisted 3.
The domestic market space is also very large it is understood that the bone implant market mainly includes hip and knee replacement implants, such as artificial joints are mainly divided into artificial knees, hips, elbows, shoulders, fingers, toes, etc. , the most important hip and knee joints total more than 95% of the global joint replacement market.
2018, 73.27 percent of China's bone joints were imported manufacturers, and domestic orthopaedic products accounted for only 26.73 percent, according to the consulting report.
69.29% of the total number of hip importers and 83.56% of the importers of knee joints.
analysis by China Industrial Information Network shows that compared with the United States, China's orthopaedic market is still in its early stages of development, the market space is large, and even in the knee area of the United States per 100,000 people implant rate is nearly 20 times that of China.
From the market share of different parts of the orthopaedic market as a whole, Chinese joints account for 24% of orthopaedics, with a high growth rate of 20.8%, while U.S. joints account for 39%, making it the largest category of orthopaedics in the United States.
the end of 2018, China's population was about 4.33 times that of the United States, with an average age of 37.3 years in China and 37.8 years in the United States.
and knee replacement surgery in the U.S. are much higher than in China.
, there were 846,000 knee replacement surgery in the United States, 192,000 in China, 4.4 times in China, 506,000 hip replacement surgery in the United States, 396,000 in China and 1.27 times in China.
joint implant penetration rate, the U.S. knee replacement implant penetration rate of 258.7 cases / 100,000 people, China 13.5 cases / 100,000 people, the United States for China 19.16 times;
accessories: